CA Stock MarketDetailed Quotes
VTAL Justera Health Ltd
- 0.010
- 0.0000.00%
15min DelayMarket Closed Nov 22 15:31 ET
2.48MMarket Cap-10000P/E (TTM)
0.010High0.010Low24.00KVolume0.010Open0.010Pre Close240.00Turnover0.02552wk High0.02%Turnover Ratio247.92MShares0.00552wk Low-0.001EPS TTM1.59MFloat Cap0.040Historical HighLossP/E (Static)158.72MShs Float0.005Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM-5.00P/B1Lot Size--Div YieldTTM
Justera Health Ltd Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 90.77%-11.99K | 62.83%-97.69K | 23.95%-813.92K | 51.79%-453.94K | 169.99%32.74K | -16.32%-129.88K | -982.63%-262.84K | -113.47%-1.07M | -941.54K | -46.78K |
| Net income from continuing operations | 96.49%-30.62K | 86.60%-122.69K | 43.25%-2.98M | 73.37%-99.36K | 45.60%-1.09M | 65.59%-872.26K | -174.22%-915.42K | 48.29%-5.25M | ---373.14K | ---2.01M |
| Operating gains losses | ---30K | ---34K | ---138.91K | --287.3K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -70.10%38.14K | -70.30%37.71K | -64.42%393.87K | -96.16%7.2K | -7.21%132.14K | -65.61%127.55K | -68.73%126.98K | -44.53%1.11M | --187.7K | --142.42K |
| Asset impairment expenditure | ---- | ---- | --4.21M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | --0 | --0 | --67.42K | ---1.41K | --0 | --0 | --68.83K | --0 | --0 | --0 |
| Other non cashItems | 101.78%5.78K | -2,743.87%-90.76K | -459.52%-4.85M | -499.25%-5.35M | 17,529.33%492.21K | -9.40%2.86K | -2.22%3.43K | -78.80%1.35M | --1.34M | --2.79K |
| Change In working capital | -99.23%4.72K | -75.28%112.06K | 43.87%2.48M | 123.30%488.4K | -48.95%928.03K | -70.14%611.97K | 1,087.18%453.35K | 33.47%1.72M | ---2.1M | --1.82M |
| -Change in receivables | 136.38%12.76K | 99.49%-1.17K | -2,229.23%-495.75K | -191.71%-280.38K | -97.03%49.99K | 85.22%-35.07K | 86.68%-230.28K | -46.19%23.28K | --305.73K | --1.68M |
| -Change in inventory | -70.73%2.5K | -99.35%586 | -80.04%394.14K | 396.10%93.09K | -74.31%201.7K | -97.03%8.55K | -89.71%90.8K | 221.36%1.97M | --18.77K | --785.12K |
| -Change in prepaid assets | --0 | 98.00%-566 | -95.32%4.62K | 397.73%243.79K | -2,387.02%-134.75K | -267.23%-76.13K | -1,570.37%-28.3K | 151.97%98.71K | --48.98K | --5.89K |
| -Change in payables and accrued expense | -101.48%-10.55K | -81.77%113.2K | 804.16%2.62M | 119.11%471.91K | 223.44%811.09K | -63.40%714.63K | -22.57%621.13K | -112.13%-371.9K | ---2.47M | ---657.09K |
| -Change in other working capital | ---- | ---- | ---40.02K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 90.77%-11.99K | 62.83%-97.69K | 23.95%-813.92K | 51.79%-453.94K | 169.99%32.74K | -16.32%-129.88K | -982.63%-262.84K | -113.47%-1.07M | ---941.54K | ---46.78K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 30K | 34K | -177.47%-360.5K | -336.79%-360.5K | 0 | 0 | 0 | 168.50%465.31K | 152.24K | 0 |
| Net PPE purchase and sale | --30K | --34K | -100.71%-236.4K | -255.28%-236.4K | --0 | --0 | --0 | 85.23%-117.78K | --152.24K | --0 |
| Net business purchase and sale | ---- | ---- | -121.28%-124.1K | ---124.1K | ---- | ---- | ---- | 394.71%583.09K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --30K | --34K | -177.47%-360.5K | -336.79%-360.5K | --0 | --0 | --0 | 168.50%465.31K | --152.24K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 21.97%-17.56K | -15.95%-25.74K | -0.34%831.69K | 2.14%898.89K | -47.06%-22.5K | -47.06%-22.5K | -48.00%-22.2K | -11.44%834.5K | 880.1K | -15.3K |
| Net issuance payments of debt | 21.97%-17.56K | -15.95%-25.74K | -57.07%-124.56K | -70.20%-57.36K | -47.06%-22.5K | -47.06%-22.5K | -48.00%-22.2K | -76.22%-79.3K | ---33.7K | ---15.3K |
| Net common stock issuance | ---- | ---- | 4.65%956.25K | ---- | ---- | ---- | ---- | -7.45%913.8K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 21.97%-17.56K | -15.95%-25.74K | -0.34%831.69K | 2.14%898.89K | -47.06%-22.5K | -47.06%-22.5K | -48.00%-22.2K | -11.44%834.5K | --880.1K | ---15.3K |
| Net cash flow | ||||||||||
| Beginning cash position | -96.55%5.26K | -78.35%94.69K | 110.51%437.42K | -97.05%10.24K | --0 | -85.23%152.38K | 110.51%437.42K | -53.42%207.79K | --346.61K | --408.68K |
| Current changes in cash | 100.30%456 | 68.62%-89.43K | -249.25%-342.72K | -6.99%84.46K | 116.49%10.24K | 75.53%-152.38K | -134.61%-285.04K | 196.36%229.63K | --90.81K | ---62.08K |
| End cash Position | --5.72K | -96.55%5.26K | -78.35%94.69K | -78.35%94.69K | -97.05%10.24K | --0 | -85.23%152.38K | 110.51%437.42K | --437.42K | --346.61K |
| Free cash from | 90.77%-11.99K | 62.83%-97.69K | 11.59%-1.05M | 12.54%-690.33K | 169.99%32.74K | -7.64%-129.88K | -13.66%-262.84K | 8.51%-1.19M | ---789.29K | ---46.78K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data